Christopher Springate
Chief Executive Officer at ARC Medical.
- Form D signer
- ARC Medical
Raised on ARC Medical filings
$1.7M
across 7 Form D filings
- Form D filings
- 7
- Teammates
- 1
- Last filing
- Oct 9, 2026
Company
Liquid barrier that prevents surgical adhesions
- Investors
- 8
ARC Medical filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Oct 9, 2026 | Equity | $167K/ $167K | Form D/A |
| Nov 10, 2025 | Equity | $1.5M/ no target | Form D/A |
| Nov 6, 2025 | Equity | $1.4M/ $1.4M | Form D/A |
| Oct 15, 2025 | Equity | $1M/ $1M | Form D/A |
| Aug 7, 2025 | Equity | $901K/ $901K | Form D/A |
| May 20, 2025 | Equity | $825K/ $825K | Form D/A |
| Mar 21, 2025 | Equity | $589K/ $589K | Form D/A |
- EquityFiled Oct 9, 2026Form D/A$167K/ $167K
- EquityFiled Nov 10, 2025Form D/A$1.5M/ no target
- EquityFiled Nov 6, 2025Form D/A$1.4M/ $1.4M
- EquityFiled Oct 15, 2025Form D/A$1M/ $1M
- EquityFiled Aug 7, 2025Form D/A$901K/ $901K
- EquityFiled May 20, 2025Form D/A$825K/ $825K
- EquityFiled Mar 21, 2025Form D/A$589K/ $589K
